Trial intelligence / Profile preview

Intravenous lidocaine infusion for postoperative quality of recovery in laparoscopic gynecological surgery

TCTR20240708004Phase 3Unknown

Sponsor
Rajavithi Hospital
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in postoperative pain, postoperative nausea and vomiting (PONV) and Delayed postoperative recovery (DPR) comparing Intravenous lidocaine infusion with Placebo infusion (2 arms). Primary endpoint: Postoperative quality of recovery. Status: unknown.

02

Drugs

lidocaine
03

Conditions

postoperative painpostoperative nausea and vomiting (PONV)Delayed postoperative recovery (DPR)

Beyond the preview

Go deeper on TCTR20240708004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240708004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call